Haitong International Securities Group logo

Haitong International Securities Group

Asia, Hong Kong Island, Hong Kong, Central

Description

Haitong International Securities Group provides various investment services, including brokerage financing, asset management, and more.

Investor Profile

Haitong International Securities Group has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 29% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (57%)
  • Series C (14%)
  • Series A (14%)
  • Series D (14%)

Country Focus

  • China (71%)
  • United States (29%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Automotive
  • Biopharma
  • Artificial Intelligence (Ai)
  • Metaverse
  • Life Science
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Haitong International Securities Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
3W Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
Oceanpine Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 1
EC
North America, New Jersey, United States, North Bergen
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Haitong International Securities Group?

MetaX

Shanghai, Shanghai, China

MetaX is a integrated circuit design company.

Artificial Intelligence (AI)Metaverse
Series BJul 5, 2022
Amount Raised: $148,811,738
YS Biopharma

Beijing, Beijing, China

YS Biopharma is a global, fully integrated bio-pharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series BFeb 24, 2021
Amount Raised: $130,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series BJul 12, 2018
Amount Raised: $14,400,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series BMar 21, 2018
Amount Raised: $125,000,000
Souche

Hangzhou, Zhejiang, China

Souche provides new and second-hand car trading services.

AutomotiveE-CommerceFinTechInternetLeasingSaaS
Series DMay 11, 2017
Amount Raised: $180,000,000
NIO

Shanghai, Shanghai, China

NIO is an automotive company that designs and develops electric autonomous vehicles.

AutomotiveAutonomous VehiclesElectric VehicleElectronicsTransportation
Series CMar 16, 2017
Amount Raised: $645,709,869
lvyouquan

Shanghai, Shanghai, China

lvyouquan is a developer of an online travel platform designed to offer product booking and transaction.

B2BMarketingTravel
Series ADec 1, 2014
Amount Raised: $19,517,952